Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Action inhibitors |
Mechanism PIM3 inhibitors(Serine/threonine-protein kinase pim-3 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |